Hao Cai

机构：Shanghai Jiao Tong University, Sichuan University, XinHua Hospital, West China Hospital of Sichuan University, Shanghai First People's Hospital · ORCID：0000-0002-1492-4701

发表论文 150 篇 · 总被引 5361 次 · h-index 36

代表论文

• Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy (2024 · Acta Pharmaceutica Sinica B · 被引 66)
• Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines (2025 · EBioMedicine · 被引 39)
• Enzyme‐Responsive Branched Glycopolymer‐Based Nanoassembly for Co‐Delivery of Paclitaxel and Akt Inhibitor toward Synergistic Therapy of Gastric Cancer (2023 · Advanced Science · 被引 37)
• Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study (2023 · International Journal of Surgery · 被引 29)
• Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA (2024 · Journal of Cellular and Molecular Medicine · 被引 9)
• Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study (2024 · International Journal of Surgery · 被引 7)